Defective co-activator recruitment in osteoclasts from microphthalmia-oak ridge mutant mice

Journal of Cellular Physiology

Volumn 220, Issue 1, 2009, Pages 230-237

  Sharma, Sudarshana M ^a   Sif, Said ^a   Ostrowski, Michael C ^a   Sankar, Uma ^a,b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b University of Louisville School of Medicine   (United States)

^c Mitchell Memorial Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; ACID PHOSPHATASE 5; BRG1 PROTEIN; CATHEPSIN K; MESSENGER RNA; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CATHEPSIN; HELICASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOENZYME; MITF PROTEIN, MOUSE; NUCLEAR PROTEIN; ONCOPROTEIN; PROTO ONCOGENE PROTEIN SPI 1; PROTO-ONCOGENE PROTEIN SPI-1; SMARCA4 PROTEIN, MOUSE; TARTRATE-RESISTANT ACID PHOSPHATASE; TNFSF11 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

AGE DISTRIBUTION; ALBERS SCHOENBERG DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE MUTATION; MOUSE; MULTINUCLEAR CELL; NEWBORN; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROMOTER REGION; STEM CELL; TRANSCRIPTION INITIATION; AGE; AGING; ANIMAL; BONE DEVELOPMENT; CELL CULTURE; COMPARATIVE STUDY; ENZYMOLOGY; GENETICS; METABOLISM; MOUSE MUTANT; MUTATION; PATHOLOGY;

MUS;

ACID PHOSPHATASE; AGE FACTORS; AGING; ANIMALS; ANIMALS, NEWBORN; CATHEPSINS; CELL DIFFERENTIATION; CELLS, CULTURED; DNA HELICASES; GENE EXPRESSION REGULATION; ISOENZYMES; MICE; MICE, MUTANT STRAINS; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MUTATION; NF-KAPPA B; NUCLEAR PROTEINS; OSTEOCLASTS; OSTEOGENESIS; OSTEOPETROSIS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; RANK LIGAND; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 65549086411     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21755     Document Type: Article

References (24)

1. Aksan I, Goding CR. 1998. Targeting the microphthalmia basic helix-loop-helix-leucine zipper transcription factor to a subset of E-box elements in vitro and in vivo. Mol Cell Biol 18:6930-6938.
2. Angel NZ, Walsh N, Forwood MR, Ostrowski MC, Cassady AI, Hume DA. 2000. Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover. J Bone Miner Res 15:103-110.
3. Boyce BF, Yao Z, Zhang Q, Guo R, Lu Y, Schwarz EM, Xing L. 2007. New roles for osteoclasts in bone. Ann N Y Acad Sci 1116:245-254.
4. Gowen M, Lazner F, Dodds R, Kapadia R, Feild J, Tavaria M, Bertoncello I, Drake F, Zavarselk S, Tellis I, Hertzog P, Debouck C, Kola I. 1999. Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J Bone Miner Res 14:1654-1663.
5. Hallsson JH, Favor J, Hodgkinson C, Glaser T, Lamoreux ML, Magnusdottir R, Gunnarsson GJ, Sweet HO, Copeland NG, Jenkins NA, Steingrimsson E. 2000. Genomic, transcriptional and mutational analysis of the mouse microphthalmia locus. Genetics 155:291-300.
6. Hayman AR, Jones SJ, Boyde A, Foster D, Colledge WH, Carlton MB, Evans MJ, Cox TM. 1996. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development 122:3151-3162.
7. Hemesath TJ, Steingrimsson E, McGill G, Hansen MJ, Vaught J, Hodgkinson CA, Arnheiter H, Copeland NG, Jenkins NA, Fisher DE. 1994. Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev 8:2770-2780.
8. Hu R, Sharma SM, Bronisz A, Srinivasan R, Sankar U, Ostrowski MC. 2007. Eos, MITF, and PU.1 recruit corepressors to osteoclast-specific genes in committed myeloid progenitors. Mol Cell Biol 27:4018-4027.
9. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
10. Luchin A, Purdom G, Murphy K, Clark MY, Angel N, Cassady AI, Hume DA, Ostrowski MC. 2000. The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts. J Bone Miner Res 15:451-460.
11. Luchin A, Suchting S, Merson T, Rosol TJ, Hume DA, Cassady AI, Ostrowski MC. 2001. Genetic and physical interactions between microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation. J Biol Chem 276:36703-36710.
12. Mansky KC, Sankar U, Han J, Ostrowski MC. 2002a. Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling. J Biol Chem 277:11077-11083.
13. Mansky KC, Sulzbacher S, Purdom G, Nelsen L, Hume DA, Rehli M, Ostrowski MC. 2002b. The microphthalmia transcription factor and the related helix-loop-helix zipper factors TFE-3 and TFE-C collaborate to activate the tartrate-resistant acid phosphatase promoter. J Leukoc Biol 71:304-310.
14. Marks SC, Jr., Lane PW. 1976. Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse. J Hered 67:11-18.
15. Meadows NA, Sharma SM, Faulkner GJ, Ostrowski MC, Hume DA, Cassady AI. 2007. The expression of Clcn7 and Ostm1 in osteoclasts is coregulated by microphthalmia transcription factor. J Biol Chem 282:1891-1904.
16. Moore KJ. 1995. Insight into the microphthalmia gene. Trends Genet 11:442-448.
17. Motyckova G, Fisher DE. 2002. Pycnodysostosis: Role and regulation of cathepsin K in osteoclast function and human disease. Curr Mol Med 2:407-421.
18. Nii A, Steingrimsson E, Copeland NG, Jenkins NA, Ward JM. 1995. Mild osteopetrosis in the microphthalmia-oak ridge mouse. A model for intermediate autosomal recessive osteopetrosis in humans. Am J Pathol 147:1871-1882.
19. Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, Moritz JD, Schu P, von Figura K. 1998. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci USA 95:13453-13458.
20. Saftig P, Hunziker E, Everts V, Jones S, Boyde A, Wehmeyer O, Suter A, von Figura K. 2000. Functions of cathepsin K in bone resorption. Lessons from cathepsin K deficient mice. Adv Exp Med Biol 477:293-303.
21. Sankar U, Patel K, Rosol TJ, Ostrowski MC. 2004. RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1. J Bone Miner Res 19:1339-1348.
22. Sharma SM, Bronisz A, Hu R, Patel K, Mansky KC, Sif S, Ostrowski MC. 2007. MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation. J Biol Chem 282:15921-15929.
23. Steingrimsson E, Moore KJ, Lamoreux ML, Ferre-D'Amare AR, Burley SK, Zimring DC, Skow LC, Hodgkinson CA, Arnheiter H, Copeland NG, et al. 1994. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nat Genet 8:256-263.
24. Tassabehji M, Newton VE, Read AP. 1994. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat Genet 8:251-255.